Top Markets
#1 MowCat MowCat +48.54%
#2 Bitway Bitway +25.99%
#3 Velvet Velvet +24.18%
#4 aPriori aPriori +19.71%
#5 OVERTAKE OVERTAKE +18.89%
#6 Biconomy Biconomy +14.82%
#7 Derive Derive +14.54%
#8 Zerebro Zerebro +13.25%
#9 Fake World Assets Fake World Assets +11.25%
#10 DODO DODO +11.08%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Phaarmasia Limited Phaarmasia Limited

Phaarmasia Limited

PHRMASI
Rank in Stocks #34335
Phaarmasia Limited is a company focused on the production of pharmaceutical... Phaarmasia Limited is a company focused on the production of pharmaceutical goods. Its range of offerings includes cosmetic items and oral birth control pills. The firm was established on February 6, 1981, and its primary office is situated in Hyderabad, India.
Share Price
$0.84987291
Last synced: 2026-08-14
Market Cap
$5.80M
Change (1 day)
-8.86%
Change (1 year)
182.30%
Country
IN
Trade Phaarmasia Limited (PHRMASI)

Category

Healthcare
Revenue for Phaarmasia Limited (PHRMASI)
Revenue in Aug 2026 TTM: 0
According to Phaarmasia Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Phaarmasia Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US